Biomarkers: Their Application in Clinical Trials

Course Description

Advances in biomarker development are revolutionising the way diseases are studied, diagnosed and treated. In this time of high clinical development costs and declining success rates, the importance of biomarkers is a principal factor in transforming drug discovery, molecular diagnostics and clinical development. Throughout the programme, delegates will have the opportunity to discuss and recognise the potential of biomarkers and how they can help the development and commercialisation process.

Data and statistical issues in biomarker discovery and validation will be explained as will the value of trial design to evaluate biomarkers for use in clinical practice.

Additionally, experts will look at the processes involved in the development of biomarkers and the future landscape for this developing area. Examples and discussion sessions are inherent throughout, encouraging a lively and positive learning environment.

CPD accreditation:
Healthcare's programmes are approved by the Faculty of Pharmaceutical Medicine for CPD accreditation. Details can be supplied on request.

Topics to be covered include:

• Biomarker assay development and validation
• Utilisation of biomarkers as a diagnosis tool
• Role of biomarkers in R&D
• Data and statistical issues in biomarker discovery
• Trial designs to evaluate biomarkers for use in clinical practice
• Biomarkers in oncology
• Cardiovascular biomarkers
• Biomarkers in CNS disease
• Biomarkers in Multiple Sclerosis
• Metabolic applications of biomarkers